Further investigation of MGP expression in other tumor types is needed, especially those for which relatively high TRPS1 or GATA3 expression has been reported, such as salivary duct carcinomas and pancreatic adenocarcinoma. This evidence concerns the gene TRPS1 and salivary duct carcinoma.